Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07449039 · ClinicalTrials.gov registry record · NA
Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial
A NA study of Gestational Diabetes Mellitus in Pregnancy, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07449039: Recruiting NA study of Gestational Diabetes Mellitus in Pregnancy, sponsored by University of California, Los Angeles.
NCT07449039 is a NA study of Gestational Diabetes Mellitus in Pregnancy that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 50 participants, below the 1,870-participant average among 9 other Gestational Diabetes Mellitus in Pregnancy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07449039, a NA study of Gestational Diabetes Mellitus in Pregnancy, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study designed to evaluate the effectiveness of continuous glucose monitoring (CGM) within hours of delivery to predict long-term risk of Type 2 Diabetes Mellitus in patients diagnosed with gestational diabetes. Participants will be provided a CGM within 2 hours after delivery and wear the device for 24 hours. Participants will be instructed to peel off the device after 24 hours. Participants will also be asked to complete two surveys regarding their experience at 1-3 months postpartum and 12-14 months postpartum.
Primary Outcome
Regression analysis to assess strength and direction of the relationship between postpartum CGM data and 2 hr GTT
Conditions Studied
Interventions
- DEVICE Continuous Glucose Monistor
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-09-28 |
| Est. Completion | 2030-06 |
| Phase | NA |
What NCT07449039 shows while recruiting
NCT07449039 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,870-participant average among 9 other Gestational Diabetes Mellitus in Pregnancy trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Gestational Diabetes Mellitus in Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monistor is the first listed.
NCT07449039 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07449039 about?
NCT07449039 is a clinical study titled "Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial". This is a pilot study designed to evaluate the effectiveness of continuous glucose monitoring (CGM) within hours of delivery to predict long-term risk of Type 2 Diabetes Mellitus in patients diagnosed with gestational diabetes. Participants will be provided a CGM within 2 hours after delivery and w...
What is the current status of trial NCT07449039?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-09-28. Estimated completion is 2030-06.
What conditions does trial NCT07449039 study?
This clinical trial studies the following conditions: Gestational Diabetes Mellitus in Pregnancy.
What interventions are being tested in trial NCT07449039?
The interventions under investigation include: Continuous Glucose Monistor (DEVICE).
Who is sponsoring clinical trial NCT07449039?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07449039 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes Mellitus in Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07449039's enrollment target sits among peer trials
50 8th of 9 higher than 1 of 9 other Gestational Diabetes Mellitus in Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gestational Diabetes Mellitus in Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of a Non-nutritive Sweetener Reduction Intervention in Pregnancy and Lactation on Maternal and Infant Outcomes
RECRUITING · NA
-
Early Detection of Gestational Diabetes Mellitus in Pregnancy
RECRUITING · NA
-
CGM for the Early Detection and Management of Hyperglycemia in Pregnancy
RECRUITING · NA
-
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
RECRUITING · NA
-
Mobile App Logging for Diabetes in Pregnancy
RECRUITING · NA
-
The CGMS in GDM Labor and Delivery Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI